A COVID-19 vaccine called AZD1222 being developed by AstraZeneca and the University of Oxford showed “robust immune responses” in early-stage clinical trials neutralizing antibody responses in 91 percent of the participants who received a single dose of AZD1222 and 100 percent of the participants who received the booster dose. The United…
Browsing: Diagnostics
This section provides information on recently published research.
Mologic has announced that, following successful independent validation by the Liverpool School of Tropical Medicine (LSTM) and St George’s, University of London, its professional-use rapid diagnostic test for COVID-19 has received a CE mark (meeting European Economic Area standards) and is ready for manufacture and global distribution. Rigorous independent assessment…
Fluxergy is collaborating with Mass General Brigham (MGB) to evaluate Fluxergy’s research-use-only COVID-19 molecular-testing platform. Fluxergy will work with the MGB Center for COVID Innovation, which was launched in late March. The so-called Diagnostic Accelerator is a collaboration between the Wyss Institute and Brigham and Women’s Hospital that aims to…
Dr. Birx wants Florida to start new ‘Pool Testing’ for COVID-19 The White House Coronavirus Task Force is looking at a groundbreaking way to boost testing and, in turn, identifying positive cases in the state. It’s called “Pool Testing,” which would allow allow large groups of people — like families…
As Reported in Tech Crunch. Everlywell was one of the first startups to announce that it was working on a self-administered, at-home COVID-19 diagnostic kit, but it initially sought out to ship kits before regulators made clear that this was not in line with its guidelines. Everlywell then became intent…
Sanofi and Luminostics to develop COVID-19 smartphone-based self-testing solution Sanofi and Luminostics to join forces on developing breakthrough COVID-19 smartphone-based self-testing solution using Luminostics’ innovative technology. a smartphone-based solution that eliminates the current need for healthcare professional administration or laboratory tests. A self-testing could help providemwhether or not they are…
A diagnostic test as simple to use as a pregnancy test. Researchers at the Broad Institute in Cambridge, Mass. announced in early May a prototype of a quick and inexpensive test for the coronarvirus, at around $6, they hope. This could overcome the shortcomings of the PCR Test. Dr. Feng…
E25Bio, a Cambridge, Massachusetts-based biotech startup that develops diagnostic tests for infectious diseases like dengue and Zika, has a new rapid antigen test for Covid-19. The company’s technologies grew out of an MIT lab led by Lee Gehrke, Professor at the Institute for Medical Engineering and Science (IMES), and Irene Bosch, then a research…